Janssen Search
Search results
Joining Forces with CEPI To Address Epidemic Threat
Joining Forces with CEPI To Address Epidemic Threat Two years ago, in January 2017, the Janssen Pharmaceutical Companies of Johnson & Johnson was proud to support the launch of the Coalition for Epidemic Preparedness Innovations (CEPI) at the World ...
Thinking Differently about Health Care: A Finnish Formula for Collaboration
Thinking Differently about Health Care: A Finnish Formula for Collaboration In our ever-evolving health care landscape, where patients’ desire for improved health and researchers’ ability to innovate grow in tandem, the medical industry is becoming more ...
The Power of Precision Medicine for Patients
The Power of Precision: How J&J is Working to Deliver the Promise of Precision Medicine to Patients with Complex Disease DNA Day on April 25 is an annual, global celebration of the discovery of the double helix structure of deoxyribonucleic acid ...
Investigational Ebola Vaccine in Sierra Leone
Maximizing the Impact of our Awareness and Development Efforts for an Investigational Ebola Vaccine in Sierra Leone The road to the EBOVAC-Salone clinic in Kambia, Sierra Leone The clinic, in Kambia, Sierra Leone, where the EBOVAC-Salone trial took place. ...
Marco Mohwinckel
Marco Mohwinckel is Global Head of Integrated Care Businesses at Janssen Healthcare Innovation. Prior to taking on this role, Marco was heading up the Neuroscience Business Unit and was a member of the United Kingdom Management Committee of Janssen ...
Cancer Interception
Cancer Interception “We want to understand what turns healthy cells into cancerous cells. This critical information will help us develop groundbreaking products to interrupt the process.” Peter F. Lebowitz, M.D., Ph.D. Global Therapeutic Area Head, ...
Marco Mohwinckel
Marco Mohwinckel is partner at Janssen Healthcare Innovation (JHI) in Europe, Middle East and Africa (EMEA). Prior to taking on this role, Marco was heading up the Neuroscience Business Unit and was a member of the United Kingdom Management Committee of ...
Mark Oswald
Mark Oswald brings more than twenty years of combined technical leadership, software development, program and product management and technology consulting experience. At Janssen Healthcare Innovation (JHI), Mark is responsible for leading the global ...
Cardiovascular, Metabolism & Retina
Cardiovascular, Metabolism & Retina At Janssen Cardiovascular, Metabolism (CVM) & Retina, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing ...
For Patients & Caregivers
Article Type: Infectious Diseases & Vaccines For Patients & Caregivers We are focused on tackling complex infectious diseases, finding the right paths of intervention, and ensuring they reach those in need. We are committed to empowering patients ...